Results for “”

Entry Author Date Location
Bio Roundup: Trump’s Budget, Biogen’s AD Reveal, Hugin’s Run & More 02/16/18 National
Syngenta Acquires Farmshots to Give Farmers Birds-Eye View of Fields 02/15/18 Raleigh Durham
Trump Budget Touts Lower Drug Prices, But No Medicare Negotiation 02/12/18 National
Medical and Patient Groups Warn Congress Against “Right to Try” 02/06/18 National
Bio Roundup: Wilson’s Warning, Amazon’s Health Biz, Moderna Cash & More 02/02/18 National
After Paper Shakes Sector, Gene Therapy Leader Jim Wilson Talks Safety 01/30/18 National
Here’s What I Made (Finally) With My Glowforge Laser Cutter 01/29/18 Seattle
Bio Roundup: Spark v. ICER, A Solid Revelation, T Cell Deals & More 01/26/18 National
Solid Discloses Duchenne Problems in IPO & Raises Rival’s Hackles 01/25/18 Boston
Hey Alexa, What’s in a Name? Actually, Let’s Call You Amazon 01/23/18 National
BioCryst, Idera Plan Merger in Tie-Up of Rare Disease Drug Developers 01/22/18 Raleigh Durham
Why Spark and Watchdog ICER Don’t See Eye-to-Eye on $850K Gene Therapy 01/22/18 National
Bio Roundup: Spark’s Road Ahead, Juno Rumors, Merck’s Big Day & More 01/19/18 National
Absences, Surprises in Amazon’s Final List of 20 Cities for HQ2 01/18/18 Seattle
Spark CEO Marrazzo on Gene Therapy Pricing & Paving the Way for the Field 01/12/18 National
Bio Roundup: #JPM18, Axovant’s Fall, CRISPR Caveat, Impact M&A & More 01/12/18 National
Notes From the JPM ’18 Vortex: Gene Therapy’s Reckoning and Lonely Cabs 01/11/18 National
Eye Drug Delivery Firm Eyenovia Sets IPO Range as Plans Come Into Focus 01/10/18 New York
Venture Activity Comes to (Unicorn) Point in 2017, and Top 10 Deals 01/09/18 National
Xconomy Bookclub: “Troublemakers” Charts the Birth of Silicon Valley 01/05/18 National
Bio Roundup: Trump, Gottlieb, Gene Therapy Prices, IPO Hopes & More 01/05/18 National
Clean Energy Entrepreneur Desai on Tech’s Pitfalls & Promise in 2017 01/03/18 Texas
First U.S. Gene Therapy, Approved for Vision Loss, to Cost $850,000 01/03/18 National
Trump v. Drug Makers? And 6 More Burning Biopharma Questions for 2018 01/02/18 National
Six Useful Things You Can Do With Your New Smart Speaker 01/02/18 National
Family & Kids’ Advocate Shum Preston on the Tech Backlash of 2017 01/02/18 San Francisco
Houston Investor Murthy Reflects on Tech’s High & Low Points in 2017 12/29/17 Texas
Security Evangelist Tony Anscombe on the Tech Backlash of 2017 12/29/17 San Diego
UTD’s Guengerich on the Promise and Peril of Tech Innovation in 2017 12/28/17 Texas
WatchHerWork CEO Hamilton: “We Are All Ready for Tech to Grow Up” 12/27/17 Texas
Page 1 of 19 next page »